Recruitment of Executive - R&D (formulation) at Titan Labs | 10 Posts
EU-GMP Manufactures of Sustained and Modified Release Pellets, DC Granules, Taste Mask Granules, Tablets and Capsules
Post: Executive - R&D (formulation)
Immunicum announced that the Company has submitted an Investigational New Drug (IND) application to the Food and Drug Administration (FDA) in the U.S. The application is requesting approval to treat kidney cancer patients in the U.S. with Immunicum’s lead cancer immune primer, INTUVAX®, in its ongoing MERECA (MEtastatic REnal cell CArcinoma) phase II-trial.